{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,17]],"date-time":"2026-11-17T23:19:19Z","timestamp":1794957559181,"version":"4.9.1"},"reference-count":45,"publisher":"Oxford University Press (OUP)","license":[{"start":{"date-parts":[[2019,8,29]],"date-time":"2019-08-29T00:00:00Z","timestamp":1567036800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>Innate immunity has been linked to initiation of Alzheimer\u2019s disease and multiple sclerosis. Moreover, risk of first-episode psychosis (FEP) and schizophrenia (Sz) is increased after various infections in predisposed individuals. Thus, we hypothesized an analogous role of innate immunity with increased C-reactive protein (CRP) in non-affective psychosis. Differential blood count, CRP, neutrophil and monocyte\u2013macrophage activation markers, cortisol and psychotic symptoms (Positive and Negative Syndrome Scale [PANSS]) were assessed in controls (n = 294) and acutely ill unmedicated FEP (n = 129) and Sz (n = 124) patients at baseline and after 6 weeks treatment. Neutrophils, monocytes, and CRP were increased in patients vs controls at baseline (P &lt; .001), and neutrophil and monocyte counts correlated positively with activation markers. Eosinophils were lower at baseline in FEP (P &lt; .001) and Sz (P = .021) vs controls. Differences in neutrophils (P = .023), eosinophils (P &lt; .001), and CRP (P &lt; .001) were also present when controlling for smoking and cortisol, and partially remitted after antipsychotic treatment. FEP patients with high neutrophils (P = .048) or monocytes (P = .021) had higher PANSS-P scores at baseline but similar disease course. CRP correlated with PANSS-P at baseline (\u03c1 = 0.204, P = .012). Improvement of positive symptoms after treatment correlated with declining neutrophils (\u03c1 = 0.186, P = .015) or CRP (\u03c1 = 0.237, P = .002) and rising eosinophils (\u03c1 = \u22120.161, P = .036). In FEP, normalization of neutrophils (\u03c1 = \u22120.231, P = .029) and eosinophils (\u03c1 = 0.209, P = .048) correlated with drug dosage. In conclusion, innate immune system activation correlated with PANSS-P, supporting the immune hypothesis of psychosis. Neutrophil and monocyte counts and CRP levels may be useful markers of disease acuity, severity, and treatment response.<\/jats:p>","DOI":"10.1093\/schbul\/sbz068","type":"journal-article","created":{"date-parts":[[2019,6,5]],"date-time":"2019-06-05T15:18:32Z","timestamp":1559747912000},"source":"Crossref","is-referenced-by-count":46,"title":["Innate Immune Cells and C-Reactive Protein in Acute First-Episode Psychosis and Schizophrenia: Relationship to Psychopathology and Treatment"],"prefix":"10.1093","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2611-2268","authenticated-orcid":false,"given":"Johann","family":"Steiner","sequence":"first","affiliation":[{"name":"Laboratory of Translational Psychiatry, Otto-von-Guericke-University Magdeburg, Magdeburg, Germany"},{"name":"Department of Psychiatry and Psychotherapy, Otto-von-Guericke-University Magdeburg, Magdeburg, Germany"},{"name":"Center for Behavioral Brain Sciences (CBBS), Magdeburg, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Frodl","sequence":"additional","affiliation":[{"name":"Department of Psychiatry and Psychotherapy, Otto-von-Guericke-University Magdeburg, Magdeburg, Germany"},{"name":"Center for Behavioral Brain Sciences (CBBS), Magdeburg, Germany"},{"name":"German Center for Neurogenerative Diseases (DZNE), Magdeburg, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kolja","family":"Schiltz","sequence":"additional","affiliation":[{"name":"Department of Psychiatry and Psychotherapy, Otto-von-Guericke-University Magdeburg, Magdeburg, Germany"},{"name":"Department of Forensic Psychiatry, Ludwig-Maximilians-University Munich, Munich, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henrik","family":"Dobrowolny","sequence":"additional","affiliation":[{"name":"Laboratory of Translational Psychiatry, Otto-von-Guericke-University Magdeburg, Magdeburg, Germany"},{"name":"Department of Psychiatry and Psychotherapy, Otto-von-Guericke-University Magdeburg, Magdeburg, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roland","family":"Jacobs","sequence":"additional","affiliation":[{"name":"Department of Clinical Immunology and Rheumatology, Hannover Medical School (MHH), Hannover, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brisa S","family":"Fernandes","sequence":"additional","affiliation":[{"name":"Department of Psychiatry, University of Toronto, Toronto, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul C","family":"Guest","sequence":"additional","affiliation":[{"name":"Laboratory of Neuroproteomics, Department of Biochemistry and Tissue Biology, University of Campinas (UNICAMP), Campinas, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabriela","family":"Meyer-Lotz","sequence":"additional","affiliation":[{"name":"Laboratory of Translational Psychiatry, Otto-von-Guericke-University Magdeburg, Magdeburg, Germany"},{"name":"Department of Psychiatry and Psychotherapy, Otto-von-Guericke-University Magdeburg, Magdeburg, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katrin","family":"Borucki","sequence":"additional","affiliation":[{"name":"Institute of Clinical Chemistry and Pathobiochemistry, Otto-von-Guericke-University Magdeburg, Magdeburg, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sabine","family":"Bahn","sequence":"additional","affiliation":[{"name":"Department of Chemical Engineering and Biotechnology, University of Cambridge, Cambridge, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bernhard","family":"Bogerts","sequence":"additional","affiliation":[{"name":"Department of Psychiatry and Psychotherapy, Otto-von-Guericke-University Magdeburg, Magdeburg, Germany"},{"name":"Center for Behavioral Brain Sciences (CBBS), Magdeburg, Germany"},{"name":"Salus Institute, Magdeburg, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Falkai","sequence":"additional","affiliation":[{"name":"Department of Psychiatry and Psychotherapy, Ludwig-Maximilians-University Munich, Munich, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hans-Gert","family":"Bernstein","sequence":"additional","affiliation":[{"name":"Laboratory of Translational Psychiatry, Otto-von-Guericke-University Magdeburg, Magdeburg, Germany"},{"name":"Department of Psychiatry and Psychotherapy, Otto-von-Guericke-University Magdeburg, Magdeburg, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2019,8,29]]},"reference":[{"issue":"7","key":"2019091012491449300_CIT0001","doi-asserted-by":"crossref","first-page":"482","DOI":"10.3109\/15622975.2011.583941","article-title":"Bridging the gap between the immune and glutamate hypotheses of schizophrenia and major depression: potential role of glial NMDA receptor modulators and impaired blood-brain barrier integrity","volume":"13","author":"Steiner","year":"2012","journal-title":"World J Biol Psychiatry"},{"issue":"1","key":"2019091012491449300_CIT0002","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1176\/appi.ajp.2007.07101637","article-title":"The risk for schizophrenia from childhood and adult infections","volume":"165","author":"Brown","year":"2008","journal-title":"Am J Psychiatry."},{"issue":"6","key":"2019091012491449300_CIT0003","doi-asserted-by":"crossref","first-page":"1526","DOI":"10.1093\/schbul\/sbt200","article-title":"Hospital contacts with infection and risk of schizophrenia: a population-based cohort study with linkage of Danish national registers","volume":"40","author":"Nielsen","year":"2014","journal-title":"Schizophr Bull."},{"key":"2019091012491449300_CIT0004","article-title":"Autoimmune encephalitis with psychosis: warning signs, step-by-step diagnostics and treatment","author":"Steiner","year":"2019","journal-title":"World J Biol Psychiatry."},{"issue":"4","key":"2019091012491449300_CIT0005","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1159\/000026501","article-title":"Immunological dysfunction in schizophrenia: a systematic approach","volume":"37","author":"Rothermundt","year":"1998","journal-title":"Neuropsychobiology."},{"issue":"5","key":"2019091012491449300_CIT0006","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1189\/jlb.0212100","article-title":"The immune theory of psychiatric diseases: a key role for activated microglia and circulating monocytes","volume":"92","author":"Beumer","year":"2012","journal-title":"J Leukoc Biol."},{"issue":"3","key":"2019091012491449300_CIT0007","doi-asserted-by":"crossref","first-page":"e1075","DOI":"10.1038\/tp.2017.4","article-title":"Immune involvement in the pathogenesis of schizophrenia: a meta-analysis on postmortem brain studies","volume":"7","author":"van Kesteren","year":"2017","journal-title":"Transl Psychiatry."},{"issue":"10","key":"2019091012491449300_CIT0008","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1016\/j.biopsych.2012.09.007","article-title":"Meta-analysis of lymphocytes in schizophrenia: clinical status and antipsychotic effects","volume":"73","author":"Miller","year":"2013","journal-title":"Biol Psychiatry."},{"key":"2019091012491449300_CIT0009","article-title":"Neutrophil count is associated with reduced gray matter and enlarged ventricles in first-episode psychosis","author":"N\u00fa\u00f1ez","journal-title":"Schizophr Bull"},{"issue":"1","key":"2019091012491449300_CIT0010","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/S2215-0366(17)30293-6","article-title":"The blood-brain barrier in psychosis","volume":"5","author":"Pollak","year":"2018","journal-title":"Lancet Psychiatry."},{"key":"2019091012491449300_CIT0011","doi-asserted-by":"crossref","first-page":"181","DOI":"10.3389\/fimmu.2017.00181","article-title":"Autoantibodies against the N-methyl-d-aspartate receptor subunit NR1: untangling apparent inconsistencies for clinical practice","volume":"8","author":"Ehrenreich","year":"2017","journal-title":"Front Immunol."},{"issue":"1","key":"2019091012491449300_CIT0012","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.neuron.2015.05.019","article-title":"Dealing with danger in the CNS: the response of the immune system to injury","volume":"87","author":"Gadani","year":"2015","journal-title":"Neuron."},{"key":"2019091012491449300_CIT0013","doi-asserted-by":"crossref","DOI":"10.1080\/15622975.2019.1583371","article-title":"Neutrophil-lymphocyte ratio, monocyte-lymphocyte ratio and platelet-lymphocyte ratio in non-affective psychosis: a meta-analysis and systematic review","author":"Mazza","year":"2019","journal-title":"World J Biol Psychiatry."},{"key":"2019091012491449300_CIT0014","doi-asserted-by":"crossref","DOI":"10.1016\/j.schres.2018.12.017","article-title":"Neutrophil-to-lymphocyte ratio in schizophrenia: a systematic review and meta-analysis","volume":"206","author":"Karageorgiou","year":"2019","journal-title":"Schizophr Res."},{"issue":"9","key":"2019091012491449300_CIT0015","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1001\/jamapsychiatry.2017.1983","article-title":"Assessment of insulin resistance among drug-naive patients with first-episode schizophrenia in the context of hormonal stress axis activation","volume":"74","author":"Steiner","year":"2017","journal-title":"JAMA Psychiatry."},{"issue":"3","key":"2019091012491449300_CIT0016","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1001\/2013.jamapsychiatry.86","article-title":"Increased prevalence of diverse N-methyl-D-aspartate glutamate receptor antibodies in patients with an initial diagnosis of schizophrenia: specific relevance of IgG NR1a antibodies for distinction from N-methyl-D-aspartate glutamate receptor encephalitis","volume":"70","author":"Steiner","year":"2013","journal-title":"JAMA Psychiatry."},{"issue":"5","key":"2019091012491449300_CIT0017","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1038\/mp.2011.42","article-title":"Identification of a biological signature for schizophrenia in serum","volume":"17","author":"Schwarz","year":"2012","journal-title":"Mol Psychiatry."},{"key":"2019091012491449300_CIT0018","first-page":"22","article-title":"The Mini-International Neuropsychiatric Interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10","volume":"59","author":"Sheehan","year":"1998","journal-title":"J Clin Psychiatry."},{"key":"2019091012491449300_CIT0019","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1192\/pb.21.4.224","article-title":"Chlorpromazine equivalents: a consensus of opinion for both clinical and research applications","volume":"21","author":"Atkins","year":"1997","journal-title":"Psychiatr Bull"},{"issue":"2","key":"2019091012491449300_CIT0020","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1097\/00004850-198904000-00001","article-title":"Guidelines for the dosage of neuroleptics. I: chlorpromazine equivalents of orally administered neuroleptics","volume":"4","author":"Rey","year":"1989","journal-title":"Int Clin Psychopharmacol."},{"issue":"6","key":"2019091012491449300_CIT0021","doi-asserted-by":"crossref","first-page":"663","DOI":"10.4088\/JCP.v64n0607","article-title":"Chlorpromazine equivalent doses for the newer atypical antipsychotics","volume":"64","author":"Woods","year":"2003","journal-title":"J Clin Psychiatry."},{"key":"2019091012491449300_CIT0022","unstructured":"Romano\n              J\n            , KromreyJD, CoraggioJ, SkowronekJ, DevineL. Appropriate statistics for ordinal level data: should we really be using t-test and cohen\u2019s d for evaluating group differences on the NSSE and other surveys?Annual meeting of the Florida Association of Institutional Research. Arlington, VA;2006:1\u201351."},{"issue":"3","key":"2019091012491449300_CIT0023","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1097\/00004714-198406000-00003","article-title":"Neuroleptic drug-induced changes in platelet levels","volume":"4","author":"Holt","year":"1984","journal-title":"J Clin Psychopharmacol."},{"key":"2019091012491449300_CIT0024","doi-asserted-by":"crossref","first-page":"S70","DOI":"10.1055\/s-2004-815513","article-title":"Blood dyscrasias induced by psychotropic drugs","volume":"37","author":"Stubner","year":"2004","journal-title":"Pharmacopsychiatry."},{"key":"2019091012491449300_CIT0025","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1111\/eip.12456","article-title":"Blood cell count in antipsychotic-naive patients with non-affective psychosis","volume":"13","author":"Garcia-Rizo","year":"2019","journal-title":"Early Interv Psychiatry."},{"key":"2019091012491449300_CIT0026","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/j.psychres.2017.11.086","article-title":"Total and differential white blood cell counts and hemodynamic parameters in first-episode psychosis","volume":"260","author":"Moody","year":"2018","journal-title":"Psychiatry Res."},{"key":"2019091012491449300_CIT0027","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1038\/mp.2015.87","article-title":"C-reactive protein is increased in schizophrenia but is not altered by antipsychotics: meta-analysis and implications","volume":"21","author":"Fernandes","year":"2016","journal-title":"Mol Psychiatry."},{"issue":"3","key":"2019091012491449300_CIT0028","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1586\/1744666X.4.3.379","article-title":"C-reactive protein at the interface between innate immunity and inflammation","volume":"4","author":"Peisajovich","year":"2008","journal-title":"Expert Rev Clin Immunol."},{"issue":"4","key":"2019091012491449300_CIT0029","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1093\/schbul\/sbx057","article-title":"The link between the immune system, environment, and psychosis","volume":"43","author":"Radhakrishnan","year":"2017","journal-title":"Schizophr Bull."},{"issue":"3","key":"2019091012491449300_CIT0030","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1056\/NEJM199307153290303","article-title":"Clozapine-induced agranulocytosis. Incidence and risk factors in the United States","volume":"329","author":"Alvir","year":"1993","journal-title":"N Engl J Med."},{"key":"2019091012491449300_CIT0031","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1111\/acps.12898","article-title":"Meta-analysis examining the epidemiology of clozapine-associated neutropenia","volume":"138","author":"Myles","year":"2018","journal-title":"Acta Psychiatr Scand."},{"issue":"1","key":"2019091012491449300_CIT0032","first-page":"5871","article-title":"Olanzapine-induced neutropenia","volume":"7","author":"Malhotra","year":"2015","journal-title":"Ment Illn."},{"issue":"9896","key":"2019091012491449300_CIT0033","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1016\/S0140-6736(13)60733-3","article-title":"Comparative efficacy and tolerability of 15 antipsychotic drugs in schizophrenia: a multiple-treatments meta-analysis","volume":"382","author":"Leucht","year":"2013","journal-title":"Lancet."},{"key":"2019091012491449300_CIT0034","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1186\/1471-244X-11-173","article-title":"Prevalence of metabolic syndrome in patients with schizophrenia, and metabolic changes after 3 months of treatment with antipsychotics\u2013results from a German observational study","volume":"11","author":"Kraemer","year":"2011","journal-title":"BMC Psychiatry."},{"issue":"19","key":"2019091012491449300_CIT0035","doi-asserted-by":"crossref","first-page":"7726","DOI":"10.1073\/pnas.1302906110","article-title":"Cigarette smoke (CS) and nicotine delay neutrophil spontaneous death via suppressing production of diphosphoinositol pentakisphosphate","volume":"110","author":"Xu","year":"2013","journal-title":"Proc Natl Acad Sci U S A."},{"key":"2019091012491449300_CIT0036","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1038\/s41380-018-0220-4","article-title":"Cerebrospinal fluid markers of inflammation and infections in schizophrenia and affective disorders: a systematic review and meta-analysis","volume":"24","author":"Orlovska-Waast","year":"2019","journal-title":"Mol Psychiatry"},{"key":"2019091012491449300_CIT0037","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.schres.2018.07.019","article-title":"Cytokines in cerebrospinal fluid of patients with schizophrenia spectrum disorders: new data and an updated meta-analysis","volume":"202","author":"Gallego","year":"2018","journal-title":"Schizophr Res."},{"issue":"10","key":"2019091012491449300_CIT0038","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1016\/j.it.2015.08.004","article-title":"GM-CSF in neuroinflammation: licensing myeloid cells for tissue damage","volume":"36","author":"Croxford","year":"2015","journal-title":"Trends Immunol."},{"issue":"4","key":"2019091012491449300_CIT0039","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1038\/nri.2017.10","article-title":"Neutrophils as protagonists and targets in chronic inflammation","volume":"17","author":"Soehnlein","year":"2017","journal-title":"Nat Rev Immunol."},{"issue":"1-3","key":"2019091012491449300_CIT0040","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/j.schres.2010.04.015","article-title":"Celecoxib treatment in an early stage of schizophrenia: results of a randomized, double-blind, placebo-controlled trial of celecoxib augmentation of amisulpride treatment","volume":"121","author":"M\u00fcller","year":"2010","journal-title":"Schizophr Res."},{"issue":"9","key":"2019091012491449300_CIT0041","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1007\/s00262-015-1723-3","article-title":"The TLR-2\/TLR-6 agonist macrophage-activating lipopeptide-2 augments human NK cell cytotoxicity when PGE2 production by monocytes is inhibited by a COX-2 blocker","volume":"64","author":"M\u00fcller","year":"2015","journal-title":"Cancer Immunol Immunother."},{"issue":"6","key":"2019091012491449300_CIT0042","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1038\/nri3686","article-title":"Innate immunity: a COX detox for the immune system?","volume":"14","author":"Bordon","year":"2014","journal-title":"Nat Rev Immunol."},{"issue":"12","key":"2019091012491449300_CIT0043","doi-asserted-by":"crossref","first-page":"1584","DOI":"10.1038\/nm.3407","article-title":"Development, maintenance and disruption of the blood-brain barrier","volume":"19","author":"Obermeier","year":"2013","journal-title":"Nat Med."},{"key":"2019091012491449300_CIT0044","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.bbi.2016.10.020","article-title":"The effect of systemic inflammation on human brain barrier function","volume":"62","author":"Elwood","year":"2017","journal-title":"Brain Behav Immun."},{"issue":"6","key":"2019091012491449300_CIT0045","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1093\/schbul\/sbq112","article-title":"Impaired kynurenine pathway metabolism in the prefrontal cortex of individuals with schizophrenia","volume":"37","author":"Sathyasaikumar","year":"2011","journal-title":"Schizophr Bull."}],"container-title":["Schizophrenia Bulletin"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/schizophreniabulletin\/advance-article-pdf\/doi\/10.1093\/schbul\/sbz068\/29227580\/sbz068.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"}],"deposited":{"date-parts":[[2019,9,10]],"date-time":"2019-09-10T14:20:17Z","timestamp":1568125217000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/schizophreniabulletin\/advance-article\/doi\/10.1093\/schbul\/sbz068\/5556303"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,8,29]]},"references-count":45,"URL":"https:\/\/doi.org\/10.1093\/schbul\/sbz068","relation":{},"ISSN":["0586-7614","1745-1701"],"issn-type":[{"value":"0586-7614","type":"print"},{"value":"1745-1701","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,8,29]]},"article-number":"sbz068"}}